Interleukin 35 (IL-35) and IL-37: Intestinal and peripheral expression by T and B regulatory cells in patients with Inflammatory Bowel Disease
Interleukin 35 (IL-35) and IL-37: Intestinal and peripheral expression by T and B regulatory cells in patients with Inflammatory Bowel Disease
复制标题
DOI：
10.1016/j.cyto.2015.04.009
复制
发表时间：
2015-10-01
期刊：
影响因子：
3.8
通讯作者：
Yamamoto-Furusho, Jesus K.
中科院分区：
文献类型：
--
作者：
Fonseca-Camarillo, Gabriela;Furuzawa-Carballeda, Janette;Yamamoto-Furusho, Jesus K.
The aim of the study was to characterize and to quantify peripheral and tissue. IL-35- and IL-37- producing cells in Inflammatory Bowel Disease (IBD) patients. We studied a total of 38 active UC, 31 inactive UC, 17 active CD, and 13 inactive CD and 50 non-inflamed tissues as control group. Gene expression was measured by real time polymerase chain reaction (RT-PCR) and protein expression was evaluated in tissue by immunohistochemistry and in peripheral blood mononuclear cells by flow cytometry. Higher levels of IL-35 was produced by intestinal regulatory B cells and circulating regulatory CD+ and CD8(+) T cells in active vs. inactive disease or healthy donors (P < 0.05). The IL-37 was conspicuously synthesized by circulating B cells, active natural killer cells and monocytes. These results suggest that down-regulation of inflammation in active IBD patients might be based on the increased expression of IL-35 and IL-37. (C) 2015 Elsevier Ltd. All rights reserved.
